Immunosuppressant compounds and compositions
US7750021B2 · kind B2 · utility
29Cited by
3References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2008 |
| Grant date | Jul 6, 2010 |
| Priority date | — |
| Expiry date | Jul 25, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D513/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to immunosuppressant, process for their production, their uses and pharmaceutical compositions containing them. The invention provides a novel class of compounds useful in the treatment or prevention of diseases or disorders mediated by lymphocyte interactions, particularly diseases associated with EDG receptor mediated signal transduction.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.